Icosavax lands $100M to take its virus-like particle vaccines into clinical trials

Icosavax Covid-19 vaccine

  Icosavax has drawn up clinical trial plans for its new type of vaccine in a strategy to commence tests of multiple programs, including a Covid-19 candidate. But really, the startup is following a path blazed by Mother Nature. The

Read More Icosavax lands $100M to take its virus-like particle vaccines into clinical trials

VectivBio, Reneo Pharma IPOs raise combined $221M for clinical trials

Wall Street sign

  The first full week of April closed with two more clinical-stage biotech companies joining the Nasdaq, each developing a drug to address rare disorders. First up was VectivBio, which raised $127.5 million to complete pivotal tests of a drug

Read More VectivBio, Reneo Pharma IPOs raise combined $221M for clinical trials

How eConsent empowers more participant engagement in clinical trials

As clinical trials move off-site, legal teams prepare for new challenges

The chances are high that you have signed at least one consent document in your life. Consents are embedded into every part of our culture. Consent to use your photograph, consent to assume the risks of skydiving, or consent for

Read More How eConsent empowers more participant engagement in clinical trials

Machine learning, AI making its way into clinical lab management

Machine learning, AI making its way into clinical lab management

While clinical labs’ use of machine learning and artificial intelligence is perhaps most prominently associated with areas like pathology and microbiology testing, these tools are also seeing uptake for lab management applications like specimen routing and billing support.These kinds of

Read More Machine learning, AI making its way into clinical lab management

Clinical leaders behind Walmart’s health strategy depart

Clinical leaders behind Walmart's health strategy depart

Walmart Health has opened 20 clinics so far, including this one in Elm Springs, Arkansas. They offer a combination of primary care, behavioral health, labs and other services. Photo credit: Walmart Walmart’s first chief medical officer and its head of

Read More Clinical leaders behind Walmart’s health strategy depart

Decentralized clinical trials are opening the drug development pipeline

As clinical trials move off-site, legal teams prepare for new challenges

There is no doubt that the Covid-19 pandemic has had a major impact on life sciences. Not only has it pushed the limits of modern medicine, but it has also created a significant backlog for clinical trials as well. More

Read More Decentralized clinical trials are opening the drug development pipeline

As clinical trials move off-site, legal teams prepare for new challenges

As clinical trials move off-site, legal teams prepare for new challenges

The Covid-19 pandemic forever changed how the life sciences industry operates. Seemingly overnight, doctors, nurses, and researchers had to transition their practices from in-person appointments to virtual engagements, a hybrid model, or even temporarily shut down. The pandemic also disrupted

Read More As clinical trials move off-site, legal teams prepare for new challenges

Inquiry finds no evidence uniQure gene therapy caused cancer in clinical trial

Global Blood Therapeutics inks deal for two sickle cell disease drugs from Sanofi

  UniQure is making a case for lifting a clinical hold on its hemophilia B gene therapy, reporting Monday results of an independent investigation that appear to clear the experimental treatment as the cause of a patient’s cancer. Last December,

Read More Inquiry finds no evidence uniQure gene therapy caused cancer in clinical trial

Design Therapeutics leads way as 4 bio IPOs raise $641M for clinical research

Wall Street sign

Momentum in biotech IPOs continued this week as four more companies made their stock market debuts. IPO activity is higher this year by several measures, according to IPO research firm Renaissance Capital. A total of 119 IPOs have been filed

Read More Design Therapeutics leads way as 4 bio IPOs raise $641M for clinical research

Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes

Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141

AbstractOBJECTIVE To establish a polyexposure score (PXS) for type 2 diabetes (T2D) incorporating 12 nongenetic exposures and examine whether a PXS and/or a polygenic risk score (PGS) improves diabetes prediction beyond traditional clinical risk factors.RESEARCH DESIGN AND METHODS We identified

Read More Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes